Blocking transferrin receptor inhibits the growth of lung adenocarcinoma cells in vitro

Publisher： John Wiley & Sons Inc

E-ISSN： 1759-7714|9|2|253-261

ISSN： 1759-7706

Source： Thoracic Cancer, Vol.9, Iss.2, 2018-02, pp. : 253-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of lung adenocarcinoma cells by insulin‐like growth factor‐I receptor and Kirsten rat sarcoma mutations: A mutation analysis with antisense oligodeoxynucleotide

By  

Thoracic Cancer, Vol. 6, Iss. 3, 2015-05 ,pp. : 260-268

John Wiley & Sons Inc

Access to resources Recommend Favorite

Subsequent treatment of epidermal growth factor receptor‐tyrosine kinase inhibitor failure in patients with advanced lung adenocarcinoma

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 678-686

John Wiley & Sons Inc

Access to resources Recommend Favorite

Efficacy of bronchoscopic biopsy for the detection of epidermal growth factor receptor mutations and anaplastic lymphoma kinase gene rearrangement in lung adenocarcinoma

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 709-714

John Wiley & Sons Inc

Access to resources Recommend Favorite

Expression of calcium sensing receptor and E‐cadherin correlated with survival of lung adenocarcinoma

By  

Thoracic Cancer, Vol. 6, Iss. 6, 2015-11 ,pp. : 754-760

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effect of inhibition proliferation in human lung adenocarcinoma A549 cells by cytokine‐induced killer cells

By  

Thoracic Cancer, Vol. 6, Iss. 4, 2015-07 ,pp. : 458-463

John Wiley & Sons Inc

Access to resources Recommend Favorite